Biotechnology Analysis & Statistics in the United States, September 2014 (p20)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

All regions

571-600 of about 1 200 reports

Purchase Reports From Reputable Market Research Publishers

Multiple Myeloma (Kahler%s Disease) - Pipeline Review, H2 2014

Multiple Myeloma (Kahler%s Disease) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Multiple Myeloma (Kahler's Disease) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H2 2014’, provides an overview of the Multiple ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : United States
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014’, provides an overview of the Chronic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Metastatic Melanoma - Pipeline Review, H2 2014

Metastatic Melanoma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Metastatic Melanoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H2 2014’, provides an overview of the Metastatic Melanoma’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014’, provides an overview of the Graft Versus ...

  • Industries : Blood Supply, Tissue Banking and Transplantation, Healthcare, Pathology, Pharmaceutical
  • Countries : United States
H1N1 Infection - Pipeline Review, H2 2014

H1N1 Infection - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

H1N1 Infection - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘H1N1 Infection - Pipeline Review, H2 2014’, provides an overview of the H1N1 Infection’s therapeutic pipeline. This report ...

  • Industries : Biopharmaceutical, Drug and Medication, Pharmaceutical, Pathology, Biotechnology
  • Countries : United States
Herpes Simplex Infections - Pipeline Review, H2 2014

Herpes Simplex Infections - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Herpes Simplex Infections - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Herpes Simplex Infections - Pipeline Review, H2 2014’, provides an overview of the Herpes Simplex Infections’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Diabetic Retinopathy - Pipeline Review, H2 2014

Diabetic Retinopathy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Diabetic Retinopathy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Diabetic Retinopathy - Pipeline Review, H2 2014’, provides an overview of the Diabetic Retinopathy’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Psoriatic Arthritis - Pipeline Review, H2 2014

Psoriatic Arthritis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Psoriatic Arthritis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Psoriatic Arthritis - Pipeline Review, H2 2014’, provides an overview of the Psoriatic Arthritis’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Novartis AG - Product Pipeline Review - 2014, Global Markets Direct

Novartis AG - Product Pipeline Review - 2014, Global Markets Direct

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

Novartis AG - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Novartis AG - Product Pipeline Review - 2014’, provides an overview of the Novartis AG’s pharmaceutical research and ...

  • Industries : Pathology
  • Countries : United States
NanoBio Corporation - Product Pipeline Review - 2014, Global Markets Direct

NanoBio Corporation - Product Pipeline Review - 2014, Global Markets Direct

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

NanoBio Corporation - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘NanoBio Corporation - Product Pipeline Review - 2014’, provides an overview of the NanoBio Corporation’s pharmaceutical ...

  • Industries : Biopharmaceutical, Drug and Medication, Research and Development
  • Countries : United States
InterMune, Inc.

InterMune, Inc.

  • $ 55
  • Company report
  • September 2014
  • by Wright Investors' Service

A textual analysis of the financial results for InterMune, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Countries : United States
Hairy Cell Leukemia - Pipeline Review, H2 2014

Hairy Cell Leukemia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Hairy Cell Leukemia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Hairy Cell Leukemia - Pipeline Review, H2 2014’, provides an overview of the Hairy Cell Leukemia’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Cerebral Palsy - Pipeline Review, H2 2014

Cerebral Palsy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Cerebral Palsy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cerebral Palsy - Pipeline Review, H2 2014’, provides an overview of the Cerebral Palsy’s therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : United States
Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014’, provides an overview of the Relapsing ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Epidermolysis Bullosa - Pipeline Review, H2 2014

Epidermolysis Bullosa - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Epidermolysis Bullosa - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Epidermolysis Bullosa - Pipeline Review, H2 2014’, provides an overview of the Epidermolysis Bullosa’s therapeutic ...

  • Industries : Pathology
  • Countries : United States, World, Europe
Genital Herpes - Pipeline Review, H2 2014

Genital Herpes - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Genital Herpes - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Genital Herpes - Pipeline Review, H2 2014’, provides an overview of the Genital Herpes’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication, Biopharmaceutical
  • Countries : United States
Sutro Biopharma, Inc. - Product Pipeline Review - 2014

Sutro Biopharma, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

Sutro Biopharma, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Sutro Biopharma, Inc. - Product Pipeline Review - 2014’, provides an overview of the Sutro Biopharma, Inc.’s ...

  • Industries : Biopharmaceutical, Research and Development, Pathology
  • Countries : United States, World
Crucell N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Crucell N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : United States
MorphoSys AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

MorphoSys AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : United States
Rosetta Genomics, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Rosetta Genomics, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Genomics, Biotechnology
  • Countries : United States
Galena Biopharma, Inc. (formerly RXi Pharmaceuticals Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Galena Biopharma, Inc. (formerly RXi Pharmaceuticals Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : United States
Generex Biotechnology Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Generex Biotechnology Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biotechnology
  • Countries : United States
Novartis Vaccines and Diagnostics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Novartis Vaccines and Diagnostics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical, General Medicine and Specialty Medicine, Diagnostics, Diagnostics, Biopharmaceutical, Drug and Medication
  • Countries : United States, United Kingdom
Antitope, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Antitope, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical, General Medicine and Specialty Medicine
  • Countries : United States
PATH (Program for Appropriate Technology in Health) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

PATH (Program for Appropriate Technology in Health) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical, Drug and Medication, Pharmaceutical
  • Countries : United States
Medicago, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Medicago, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United States
International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy, Biotechnology, Investment Banking
  • Countries : United States, United Kingdom
Novavax, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Novavax, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : United States
GenVec, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

GenVec, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Healthcare
  • Countries : United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.